Nanoparticulate materials and regulatory policy in Europe: An analysis of stakeholder perspectives
Source abstract
Abstract
The novel properties of nanoparticulate materials (NPM) and the rapid development of NPM based products have raised many unanswered questions and concerns by different stakeholders over its consequences for the environment and human health. These concerns have led to an increasing discussion in both the US and Europe about possible regulatory policies for NPM. In this article a comparative study of stakeholders’ perceptions on regulatory policy issues with NPM in Europe is presented. It was found that industry wants to regulate this area if the scientific evidence demonstrates that NPM are harmful, but also that the regulatory bodies do not find it necessary at this point of time to regulate until scientific evidence demonstrates that NPM are harmful. This research therefore shows that there will most likely not be any regulatory interventions until there is an established and convincing scientific knowledge base demonstrating that NPM can be hazardous. It is furthermore discussed in this article the different roles and responsibilities of the stakeholders in financing the research required to establish the necessary level of fundamental scientific evidence. It was also found that the activity of the regulatory bodies on this issue differ between the European countries.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Air Quality and Health Impacts · Nanoparticles: synthesis and applications · Microplastics and Plastic Pollution
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Borm P.J., 2004. In: Helland A. (ed.) Nanoparticles: A Closer Look to the Risks to Human Health and the Environment. Perceptions and Precautionary Measures of Industry and Regulatory Bodies in Europe. Vol. IIIEE Reports 2004:05. Lund University, Lund: IIIEE, pp. 21–23.
2. Borm P.J., Kreyling W. (2004). Toxicological hazards of inhaled nanoparticles-potential implications for drug delivery. J. Nanosci. Nanotechnol. 4(5): 521–53110.1166/jnn.2004.081 ↗
3. Bourne L., Walker D. (2005). Visualising and mapping stakeholder influence. Manage. Decis. 43(5): 649–66010.1108/00251740510597680 ↗
4. Donaldson K., 2004a. The Toxicology of Airborne Nanoparticles. In: Health and Safety Laboratory, Nanomaterials: A␣Risk to Health at Work? Derbyshire, UK.
5. Donaldson K., 2004b. In: Helland A. (ed.) Nanoparticles: A␣Closer Look to the Risks to Human Health and the Environment. Perceptions and Precautionary Measures of Industry and Regulatory Bodies in Europe. Vol. IIIEE Reports 2004:05. Lund University, Lund: IIIEE, p. 22.
6. Donaldson K., Brown D., Clouter A., Duffin R., MacNee W., Renwick L., Tran L., Stone V. (2002). The pulmonary toxicology of ultrafine particles. J. Aerosol. Med. 15(2): 213–22010.1089/089426802320282338 ↗
7. EC, 2000. Communication from the commission on the precautionary principle. European Commission, Brussels
8. EC, 2003. Proposal for a regulation of the European parliament and of the council concerning the registration, evaluation, authorisation and restriction of chemicals (reach), establishing a european chemicals agency and amending directive 1999/45/ec and regulation (ec) {on persistent organic pollutants}. European Commission, Brussels
9. EC, 2004. Communication from the commission: Towards a European strategy for nanotechnology. European Commission, Brussels
10. EC, 2005a. Communication from the commission: Nanosciences and nanotechnologies: An action plan for Europe 2005–2009. European Commission, Brussels
11. EC, 2005b. REACH: Commission welcomes council’s agreement on new EU chemical legislation. Retrieved February 13, 2006, from http://www.europa.eu.int/rapid/pressReleases Action.do?reference= IP/05/1583&format=HTML&aged= 0&language=EN&guiLanguage=en
12. Fortner J., Lyon D., Sayes C., Boyd A., Falkner J., Hotze E., Alemanny L., Tao Y., Guo W., Ausman K., Colvin V.L., Hughes J. (2005). C60 in water: Nanocrystal formation and microbial response. Environ. Sci. & Technol. 39(11): 4307–431610.1021/es048099n ↗
13. Haum R., Petschow U., Steinfeldt M. (2004). Nanotechnology and regulation within the framework of the precautionary principle. Institut für ökologische Wirtschaftsforschung, Berlin
14. Helland A., 2004. Nanoparticles: A Closer Look at the Risks to Human Health and the Environment-Perceptions and Precautionary Measures of Industry and Regulatory Bodies in Europe. No. IIIEE Report: 2004:05. Lund University, Lund: IIIEE.
15. Hett A., 2004. Nanotechnology. Small matter, many unknowns (http://www.swissre.com/INTERNET/pwsfilpr.nsf/vwFileby IDKEYLu/ULUR-5YNGET/$FILE/Publ04_Nanotech_en. pdf). Zurich: Swiss Reinsurance Company.
16. ICCA, 2005. Responsible care. Retrieved September 22, 2005, from http://www.responsiblecare.org/
17. ICON, 2005. Review of best practices for nanomaterial safety: A request for proposals. Retrieved 31 January, 2006, from http://www.cohesion.rice.edu/centersandinst/icon/projects. cfm?doc_id=4388
18. IRGC, 2004. Nanotechnology. Retrieved February 7, 2006, from http://www.irgc.org/
19. Kreyling W., Semmler M., Erbe F., Mayer P., Takenaka S., Schulz H., Oberdorster G., Ziesenis A. (2002). Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J. Toxicol. Environ. Health A 65(20): 1513–153010.1080/00984100290071649 ↗
20. Lam C.-W., James J.T., McCluskey R., Hunter R.L. (2004). Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 77: 126–13410.1093/toxsci/kfg243 ↗
21. Muller J., Huaux F., Moreau N., Misson P., Heilier J.-F., Delos M., Arras M., Fonseca A., Nagy J., Lison D. (2005). Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharm. 207(3): 221–23110.1016/j.taap.2005.01.008 ↗
22. Nanosafe, 2006. Safe production and use of nanomaterials. Retrieved February 7, 2006, from http://www.nanosafe.org/node/15
23. Nemmar A., Vanbilloen H., Hoylaerts M.F., Hoet P.H., Verbruggen A., Nemery B. (2001). Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am. J. Respir. Crit. Care Med. 164(9): 1665–166810.1164/ajrccm.164.9.2101036 ↗
24. NSTC, 1999. Nanotechnology: Shaping the world atom by atom. National Science and Technology Council, Washington, DC
25. Oberdorster E. (2004a). Manufactured nanomaterials (fullerenes, c60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health Persp. 112(10): 1058–106210.1289/ehp.7021 ↗
26. Oberdorster E., 2004b. In: Helland A. (ed.) Nanoparticles: A Closer Look to the Risks to Human Health and the Environment. Perceptions and Precautionary Measures of Industry and Regulatory Bodies in Europe. Vol. IIIEE Reports 2004:05. Lund University, Lund: IIIEE, p. 22.
27. Oberdorster G. (2001). Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup. Env. Hea. 74(1): 1–8
28. Oberdorster G., E. Oberdorster & J. Oberdorster, 2005. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles. National Institute of Environmental Health Sciences.10.1289/ehp.7339 ↗
29. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., Cox C. (2004). Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16(6–7): 437–44510.1080/08958370490439597 ↗
30. Oberdorster G., Sharp Z., Atudorei V., Elder A., Gelein R., Lunts A., Kreyling W., Cox C. (2002). Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health A 65(20): 1531–154310.1080/00984100290071658 ↗
31. Roco M.C. (2005). The emergence and policy implications of converging new technologies integrated from the nanoscale. J. Nanoparticle Res. 7:129–14310.1007/s11051-005-3733-0 ↗
32. Sayes C.M., Liang F., Hudson J.L., Mendez J., Guo W., Beach J.M., Moore V.C., Doyle C.D., West J.L., Billups W.E., Ausman K.D., Colvin V.L. (2006). Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol. Lett. 161(2): 135.10.1016/j.toxlet.2005.08.011 ↗
33. Service R.F. (2004). Nanotechnology grows up. Science 304:1732–173410.1126/science.304.5678.1732 ↗
34. Shvedova A.A., E.R. Kisin, R. Mercer, A.R. Murray, V.J. Johnson, A.I. Potapovich, Y.Y. Tyurina, O. Gorelik, S. Arepalli, D. Schwegler-Berry, A.F. Hubbs, J. Antonini, D.E. Evans, K. Bon-Ki, D. Ramsey, A.D. Maynard, V.E. Kagan, V. Castranova & P.A. Baron, 2005. Unusual inflammatory and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell Mol. Physiol. June 10 (Epub ahead of print).10.1152/ajplung.00084.2005 ↗
35. Stone V., 2004. In: Helland A. (ed.) Nanoparticles: A Closer Look to the Risks to Human Health and the Environment. Perceptions and Precautionary Measures of Industry and Regulatory Bodies in Europe. Vol. IIIEE Reports 2004:05. Lund University, Lund: IIIEE, pp. 21–23.
36. Takenaka S., Karg E., Kreyling W., Lentner B., Schulz H., Ziesenis A., Schramel, P., & Heyder, J. (2004). Fate and toxic effects of inhaled ultrafine cadmium oxide particles in the rat lung. Inhal. Toxicol. 16(Suppl. 1): 83–9210.1080/08958370490443141 ↗
37. Takenaka S., Karg E., Roth C., Schulz H., Ziesenis A., Heinzmann U., Schramel P., Heyder J. (2001). Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 109(Suppl. 4): 547–551
38. The Royal Society & The Royal Academy of Engineering, 2004. Nanoscience and nanotechnologies: Opportunities and uncertainties ( http://www.nanotec.org.uk/finalReport.htm ): The Royal Society & The Royal Academy of Engineering.
39. von Klot S., A. Peters, P. Aalto, T. Bellander, N. Berglind, D.␣D’Ippoliti, R. Elosua, A. Hormann, M. Kulmala, T.␣Lanki, H. Lowel, J. Pekkanen, S. Picciotto, J. Sunyer, F.␣Forastiere; Health Effects of Particles on Susceptible Subpopulations Study Group, 2005. Ambient air pollution is associated with increased risk of hospital cardiac readmissions of myocardial infarction survivors in five european cities. Circulation 112(20), 3073–3079.10.1161/CIRCULATIONAHA.105.548743 ↗
40. Warheit D.B. (2004). Nanoparticles: Health impacts?. Materials Today 7(2): 32–3510.1016/S1369-7021(04)00081-1 ↗
41. Warheit D.B., Laurence B.R., Reed K.L., Roach D.H., Reynolds G.A., Webb T.R. (2004). Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 77(1): 117–12510.1093/toxsci/kfg228 ↗
42. Zhang Q., Kusaka Y., Zhu X., Sato K., Mo Y., Kluz T., Donaldson K. (2003). Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J. Occup. Health 45(1): 23–3010.1539/joh.45.23 ↗